Managing cardiometabolic risk in women with gestational diabetes using continuous glucose monitoring and mobile health
Official title: The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus: The Development and Application of "a Lifestyle Intervention Based on Health Belief Model Supported by Mobile Health"
Run by National Taiwan University Hospital · NCT06648174 · Data updated 2026-11-12
This trial will test whether continuous glucose monitoring plus a mobile health lifestyle program helps pregnant women with gestational diabetes control blood sugar and lower cardiometabolic risk for them and their babies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu) |
| Status | Recruiting |
| Started | November 11, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT06648174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 or older diagnosed with gestational diabetes who can attend study visits at the Hsinchu site and are willing to use CGM and mobile health tools are ideal candidates.
✕Probably not a fit
Women with preexisting diabetes, known tape allergies, abnormal coagulation, or those unable or unwilling to use CGM or mobile technology may not receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 120 pregnant women with gestational diabetes in Hsinchu, Taiwan and randomly assign them to routine finger‑prick monitoring, continuous glucose monitoring (CGM) alone, or CGM plus a health belief model–based lifestyle and mHealth program delivered from mid‑pregnancy through the postpartum period. The behavioral intervention is family‑centered and delivered via mobile health at 24–32 weeks, continued until delivery, with follow-up at 4–12 weeks postpartum. Outcomes measured at baseline, late pregnancy, and postpartum include maternal glycemic parameters, cardiometabolic risk markers, health behaviors, and infant outcomes. The trial will compare changes across the three arms to see if CGM and the added mHealth lifestyle program improve short‑term glucose control and early cardiometabolic indicators.
Why it matters
Potential benefit: If successful, the combined CGM plus mHealth lifestyle program could improve blood sugar control during and after pregnancy, reduce mothers' early cardiometabolic risk, and improve infant outcomes.
How similar studies have gone: Previous work shows CGM can improve short‑term glucose control in gestational diabetes, but evidence is limited on long‑term cardiometabolic benefit and on combining CGM with an HBM‑based mHealth lifestyle program across pregnancy and postpartum.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18 years or above 2. Pregnant women diagnosed with gestational diabetes mellitus 3. Willing to participate in the study Exclusion Criteria: 1. Diagnosed with diabetes mellitus before pregnancy 2. Allergic to materials such as tapes (e.g., redness, swelling, itching, pain, blisters, or rashes caused by breathable tapes or patches) 3. Abnormal coagulation function
Where it's running
-
National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
Hsinchu, Taiwan Recruiting
Study contacts
- Principal investigator: HUNG-HUI CHEN, PhD — National Taiwan University Hostiptal
- Study coordinator: HUNG-HUI CHEN, PhD
- Email: hunghuichen@ntu.edu.tw
- Phone: 886-2-2394-7109
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Continuous glucose monitoring for pregnant women with gestational diabetes to improve mother and baby outcomes
This project will test whether using continuous glucose monitoring helps pregnant women with gestational diabetes and their babies have better health outcomes than usual monitoring.
-
Islet function in gestational diabetes: see if pancreas changes during and after pregnancy
This study tests whether the human pancreas changes its function during and after pregnancy in people with gestational diabetes or not, using Exendin 9-39 in a small Phase 1 trial.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
How dexamethasone affects blood sugar during and after non-cardiac surgery
We will see if a standard dose of dexamethasone raises blood sugar in adults having elective non-cardiac surgery and whether continuous glucose monitors detect changes better than finger-prick tests.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Glucose monitoring in women with polycystic ovary syndrome
This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.